Brentview Investment Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.55M Buy
43,235
+500
+1% +$138K 3.78% 6
2026
Q1
$12.6M Buy
42,735
+666
+2% +$198K 5.46% 2
2025
Q4
$11.5M Buy
42,069
+89
+0.2% +$24.2K 5.19% 3
2025
Q3
$11.3M Buy
41,980
+578
+1% +$157K 5.17% 3
2025
Q2
$11.4M Sell
41,402
-292
-0.7% -$79.4K 5.76% 2
2025
Q1
$11.1M Buy
41,694
+851
+2% +$210K 5.88% 2
2024
Q4
$9.49M Buy
+40,843
New +$9.39M 5.39% 3

Other funds holding CME

Brentview Investment Management's CME Position: Q2 2026 in Review

Brentview Investment Management increased its CME Group (CME) stake by 1.2% in Q2 2026, buying an estimated $138K and bringing the position to 43,235 shares worth $9.55M. The position accounts for 3.78% of the portfolio, ranked #6.

Brentview Investment Management first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.6M in Q1 2026. 670 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Brentview Investment Management held 43,235 shares of CME Group worth $9.55M as of Q2 2026.
  • Brentview Investment Management bought 500 CME Group shares in Q2 2026, an estimated $138K.
  • CME Group made up 3.78% of Brentview Investment Management's portfolio in Q2 2026, its #6 holding.
  • Brentview Investment Management first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • Brentview Investment Management's CME Group position peaked at $12.6M in Q1 2026.
  • 670 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Brentview Investment Management's 13F filing for Q2 2026, filed 30 Jul 2026.